POWERbreathe® Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis.
Ontology highlight
ABSTRACT: Inspiratory muscle training may benefit respiratory function, cardiocirculatory parameters, quality of life and functionality in neuromuscular diseases. This pilot study aimed to demonstrate the POWERbreathe® inspiratory muscle training effects on maximum inspiratory pressure (PImax), heart rate (HR) and HR variability, as well as the quality of life impairment and functionality in patients with Amyotrophic Lateral Sclerosis (ALS). A pilot single-blinded, non-randomized controlled clinical trial was carried out. A total of 20T ALS patients were enrolled and divided into experimental (n = 10) and control (n = 10) groups. The experimental group received POWERbreathe® inspiratory muscle training in conjunction with usual care, and the control group received only usual care for 8 weeks. PImax
SUBMITTER: Vicente-Campos D
PROVIDER: S-EPMC9698064 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA